PAG
CTSO icon

Private Advisor Group’s Cytosorbents Corp CTSO Stock Holding History

Private Advisor Group’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-10,000
Closed -$43K – 1478
2017
Q2 		$43K Buy
+10,000
New +$43.8K ﹤0.01% 1359

Other funds holding CTSO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SC
Skylands Capital Milwaukee, Wisconsin $763M AUM 26.49% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
MHP
Manatuck Hill Partners Westport, Connecticut $370M AUM 95.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PG
PEAK6 Group Chicago, Illinois $23.4B AUM 17.65% 1-Year Est. Return
WAP
Wealthcare Advisory Partners West Chester, Pennsylvania $5.27B AUM 22.23% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Private Advisor Group's CTSO Position: Q3 2017 in Review

Private Advisor Group sold out of Cytosorbents Corp (CTSO) in Q3 2017, closing a stake of 10,000 shares — an estimated $43K sold.

Private Advisor Group first reported a position in CTSO in Q2 2017 and held it in 1 quarter. The position peaked at $43K in Q2 2017. 31 funds tracked by Wall St. Rank hold CTSO as of Q3 2017.

  • Private Advisor Group reported no remaining Cytosorbents Corp position as of Q3 2017 after selling out during the quarter.
  • Private Advisor Group sold 10,000 Cytosorbents Corp shares in Q3 2017, an estimated $43K.
  • Private Advisor Group first reported a position in Cytosorbents Corp in Q2 2017 and held it in 1 quarter.
  • Private Advisor Group's Cytosorbents Corp position peaked at $43K in Q2 2017.
  • 31 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q3 2017.

Based on Private Advisor Group's 13F filing for Q3 2017, filed 13 Nov 2017.